Flow cytometry in primary patient and healthy donor bone marrow confirmed FCRL2 surface expression on MM cells in 7 of 11 patients and showed moderate or low expression on healthy plasma and B cells and other hematopoietic cells, respectively (Fig. 7d,e and Extended Data Fig. 9f,g). This evidence concerns the gene FCRL2 and Miyoshi myopathy.